Medication info
Ultraset ER Extended Release Tablet

Ultraset ER Extended Release Tablet

Prescription medicationTabletOral
Ingredient · strength
Acetaminophen›390mg / 1 tabletTramadol Hydrochloride›58mg / 1 tablet
Manufacturer / importer
(Co., Ltd.) Korea Janssen
Appearance
Yellow oblong film-coated sustained-release tablet
Packaging
1 - 50 tablets/box [10 tablets/PTP x 5], 1 - 100 tablets/bottle
Approval status
Active

MFDS item code 202201173 · Approved 2022.03.24 · Insurance code 646902650

Summary

Main use
Relief of moderate to severe chronic pain
Who takes it
Adults
Adult dose
Adults: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 1 tablet is recommended. Thereafter, allow at least 12 hours between doses and do not exceed 4 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this medicine for longer than necessary. If long-term treatment is required due to the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued. Nausea, vomiting, itching, constipation, dizziness, and somnolence may occur when this medicine is administered; therefore, closely monitor the patient's response and adjust treatment as appropriate. Elderly: Administer the usual adult dose. However, when tramadol is administered orally to elderly patients aged 75 years and older, the elimination half-life of tramadol increased by 17%; therefore, administer this medicine at intervals of at least 12 hours. Patients with renal impairment: The safety and efficacy of this medicine have not been established in patients with renal impairment; therefore, use is not recommended. Patients with hepatic impairment: The safety and efficacy of this medicine have not been established in patients with hepatic impairment; therefore, use is not recommended.

Ingredients

Manufacturer
(Co., Ltd.) Korea Janssen

Efficacy & effects

Relief of moderate to severe chronic pain

  • Chronic pain
View approved original text

This medication is used for the treatment of moderate to severe chronic pain.

How to take

Adult dose

Adults: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 1 tablet is recommended. Thereafter, allow at least 12 hours between doses and do not exceed 4 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this medicine for longer than necessary. If long-term treatment is required due to the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued. Nausea, vomiting, itching, constipation, dizziness, and somnolence may occur when this medicine is administered; therefore, closely monitor the patient's response and adjust treatment as appropriate. Elderly: Administer the usual adult dose. However, when tramadol is administered orally to elderly patients aged 75 years and older, the elimination half-life of tramadol increased by 17%; therefore, administer this medicine at intervals of at least 12 hours. Patients with renal impairment: The safety and efficacy of this medicine have not been established in patients with renal impairment; therefore, use is not recommended. Patients with hepatic impairment: The safety and efficacy of this medicine have not been established in patients with hepatic impairment; therefore, use is not recommended.

Precautions

This medication may strain the liver, so individuals who regularly consume more than three alcoholic drinks per day must consult a doctor or pharmacist. During the use of this medication, serious skin reactions such as rashes or blisters may develop; if such symptoms occur, the treatment should be stopped immediately, and medical advice should be sought. One of the components of this medication may increase the risk of seizures, so individuals with a history of seizures or those at risk should be cautious when taking it, especially when combined with certain antidepressants or other medications. Rarely, during treatment, severe allergic reactions may occur; if symptoms such as difficulty breathing or hives appear, medical personnel should be notified immediately. Patients with acute bronchial asthma are at risk of severe respiratory suppression while taking this medication, so it should be administered carefully in a medically equipped setting. Co-administration with alcohol or certain sedatives can cause severe drowsiness or respiratory suppression leading to coma, so concurrent use should be avoided or done under medical supervision. Patients with head injuries or increased intracranial pressure need to be cautious as respiratory suppression caused by this medication may worsen symptoms. This medication has the potential to cause psychological or physical dependence, so the risk of dependence should be regularly assessed during long-term use. Patients with impaired liver function should consult a doctor before taking this medication, as its components may cause liver damage, and it should not be taken with other acetaminophen products. Patients with specific genetic profiles may have faster metabolism of this medication, resulting in higher blood concentrations and serious respiratory suppression; dose adjustment or alternative medications may be necessary in such cases. This medication is not to be administered to children under 12 years or adolescents under 18 years who have undergone tonsillectomy or adenoidectomy. Patients with sleep apnea or hypoxia should be closely monitored for worsening symptoms during treatment, and dosage may need to be reduced or discontinued if necessary. Elderly patients or those with specific diseases may experience electrolyte imbalances like hyponatremia and require regular monitoring. Patients with biliary tract disease or a history of gallbladder surgery should be cautious about the possibility of acute pancreatitis. This medication should not be given to individuals allergic to its components, those with central nervous system drug intoxication, severe respiratory suppression, head injuries, or those currently taking MAO inhibitors. Patients taking narcotic analgesics or central nervous system depressants should be careful with this medication due to interaction risks that heighten side effect risks. During the use of this medication, patients should be cautious when driving or operating dangerous machinery as drowsiness or dizziness may occur. In case of overdose, serious respiratory suppression, seizures, or liver damage may occur; therefore, prescribed dosages must be adhered to, and emergency medical assistance should be contacted immediately.

Side effects

  • Liver damage
  • acute generalized eruptive pustulosis
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • seizures
  • anaphylactic reactions
  • respiratory depression
  • deep sedation
  • coma
  • death
Show 185 more
  • dizziness
  • headache
  • drowsiness
  • nausea
  • vomiting
  • constipation
  • dry mouth
  • diarrhea
  • dyspepsia
  • abdominal pain
  • abdominal discomfort
  • flatulence
  • pruritus
  • sweating
  • rash
  • fatigue
  • flushing
  • urticaria
  • hypersensitivity
  • hypoglycemia
  • insomnia
  • depression
  • anxiety
  • irritability
  • emotional instability
  • euphoria
  • decreased libido
  • confusion
  • disorientation
  • agitation
  • abnormal dreams
  • drug abuse
  • hallucinations
  • withdrawal syndrome
  • migraine
  • hypersomnia
  • sensory impairment
  • tremors
  • paresthesia
  • attention disorder
  • syncope
  • memory impairment
  • psychomotor hyperactivity
  • sedation
  • amnesia
  • perceptual disturbances
  • seizures
  • blurred vision
  • visual impairment
  • miosis
  • dizziness
  • tinnitus
  • ear discomfort
  • palpitations
  • tachycardia
  • hypertension
  • hypotension
  • dyspnea
  • dry throat
  • elevated liver enzymes
  • generalized pruritus
  • diaphoresis
  • urinary dysfunction
  • erectile dysfunction
  • weakness
  • chest pain
  • emotional abnormality
  • chills
  • chest discomfort
  • lethargy
  • drug withdrawal syndrome
  • thirst
  • irritability
  • heat sensation
  • weight loss
  • elevated serum creatinine
  • leukonychia
  • rhinitis
  • nasopharyngitis
  • limb pain
  • arthralgia
  • muscle cramps
  • muscle weakness
  • myalgia
  • blurry vision
  • conjunctivitis
  • decreased immune response
  • paresthesia
  • lethargy
  • taste disturbances
  • involuntary muscle contractions
  • tremors
  • migraine
  • dark urine
  • anuria
  • urinary retention
  • urinary incontinence
  • oliguria
  • abdominal distension
  • upper abdominal discomfort
  • upper abdominal pain
  • peptic ulcer
  • belching
  • chest discomfort
  • facial swelling
  • chills
  • fever
  • peripheral edema
  • pallor
  • blood pressure fluctuations
  • cough
  • rhinorrhea
  • hematuria
  • hypertension
  • palpitations
  • irregular menstrual cycle
  • breast cancer
  • injury
  • hyponatremia
  • fixed rash
  • hyperprolactinemia
  • adrenal insufficiency
  • anaphylaxis
  • bronchospasm
  • toxic skin necrosis
  • Stevens-Johnson syndrome
  • delirium
  • suicidal thoughts
  • muscle hypertonicity
  • movement disorders
  • serotonin syndrome
  • speech disorders
  • mydriasis
  • orthostatic hypotension
  • hepatitis
  • gait disturbances
  • prolonged prothrombin time
  • lactic acidosis
  • high anion gap metabolic acidosis
  • paralytic ileus
  • cholecystitis
  • confusion
  • disorientation
  • multiple organ failure
  • intentional overdose
  • belching
  • heartburn
  • acute gastritis
  • cold
  • upper respiratory infection
  • generalized weakness
  • motion sickness
  • transient ischemic attack
  • lethargy
  • drowsiness
  • depersonalization
  • anemia
  • decreased hemoglobin
  • decreased erythrocytes
  • decreased leukocytes
  • increased leukocytes
  • decreased platelets
  • arrhythmia
  • exacerbation of hypertension
  • aortic stenosis
  • hemorrhage
  • elevated cholesterol
  • tinnitus
  • chills
  • hip pain
  • thigh pain
  • allergic rhinitis
  • epistaxis
  • abnormal vision
  • progress of biliary cancer
  • foreign body sensation in the eye
  • progression of liver cancer
  • liver function abnormalities
  • congestive heart failure
  • vertigo
  • confusion
  • loss of consciousness
  • recurrence of myocardial infarction
  • hypotension
  • hyperhidrosis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to avoid exposure to air or moisture. It is recommended to maintain a storage temperature between 1 degree and 30 degrees at room temperature to preserve the effectiveness of the medication.

Appearance and packaging

Appearance

Yellow oblong film-coated sustained-release tablet

Package unit

1 - 50 tablets/box [10 tablets/PTP x 5], 1 - 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.